期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 偏慢,4-8周

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

《分子癌癥研究》發(fā)表的文章描述了該領(lǐng)域廣泛關(guān)注的新型基礎(chǔ)癌癥研究發(fā)現(xiàn)。研究必須具有顯著意義，該期刊優(yōu)先考慮在分子和細(xì)胞水平上進(jìn)行的分析，這些分析揭示了與癌癥風(fēng)險(xiǎn)、發(fā)展和/或進(jìn)展相關(guān)的途徑和過(guò)程的新機(jī)制見(jiàn)解。重點(diǎn)領(lǐng)域包括所有與癌癥相關(guān)的途徑（包括細(xì)胞周期調(diào)控；細(xì)胞死亡；染色質(zhì)調(diào)控；DNA 損傷和修復(fù)；基因和 RNA 調(diào)控；基因組學(xué)；致癌基因和腫瘤抑制因子；信號(hào)轉(zhuǎn)導(dǎo)；以及腫瘤微環(huán)境），以及描述支持癌癥表型的新分子機(jī)制和相互作用的研究。為了獲得充分考慮，主要研究提交必須提供對(duì)現(xiàn)有途徑功能的重大新見(jiàn)解或解決與癌癥相關(guān)的生物學(xué)問(wèn)題相關(guān)的新假設(shè)。

《Molecular Cancer Research》(分子癌癥研究)編輯部通訊方式為AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。